Barrier Function and Terminal Synergetic-Based Controllers for the Chemotherapy of Brain Tumor

Lumps formed by abnormal cell growth in the brain constitute brain tumors. Treatments differ depending on the specificity of the tumor and the condition of the patient; surgery, radiation therapy and targeted therapy are suggested for less severe tumors, while for severe tumors; chemotherapy is reco...

Full description

Saved in:
Bibliographic Details
Main Authors: Muhammad Zubair, Daniela Iacoviello, Sheraz Ahmad Babar
Format: Article
Language:English
Published: IEEE 2025-01-01
Series:IEEE Access
Subjects:
Online Access:https://ieeexplore.ieee.org/document/10900338/
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850027775639945216
author Muhammad Zubair
Daniela Iacoviello
Sheraz Ahmad Babar
author_facet Muhammad Zubair
Daniela Iacoviello
Sheraz Ahmad Babar
author_sort Muhammad Zubair
collection DOAJ
description Lumps formed by abnormal cell growth in the brain constitute brain tumors. Treatments differ depending on the specificity of the tumor and the condition of the patient; surgery, radiation therapy and targeted therapy are suggested for less severe tumors, while for severe tumors; chemotherapy is recommended. The last one, while being suggested and effective also in conjunction with surgery, has side effects that could be fatal. Therefore, it is mandatory to determine the appropriate dosage to obtain the desired effects without affecting healthy and immune cells. In this research work, advanced barrier function-based sliding mode and terminal synergetic-based controllers are designed to determine the amount of chemotherapy to eliminate tumor cells and maintain the right amount of healthy and immune cells. In particular, a barrier-based sliding mode controller is designed for dynamically controlling the chemotherapy drug for the tumor system, whereas the stability and convergence of the system are checked using the Lyapunov theory. The performance of the controller has been verified using MATLAB software based on different control parameters. The controller has remained successful in reducing the tumor cells and maintaining safe number of healthy and immune cells, showing favorable results in terms of steady-state error, over-under shoots, and rate of convergence.
format Article
id doaj-art-3e2fc515c2a745c0a5c700d1603cd8cd
institution DOAJ
issn 2169-3536
language English
publishDate 2025-01-01
publisher IEEE
record_format Article
series IEEE Access
spelling doaj-art-3e2fc515c2a745c0a5c700d1603cd8cd2025-08-20T03:00:02ZengIEEEIEEE Access2169-35362025-01-0113362013621110.1109/ACCESS.2025.354475710900338Barrier Function and Terminal Synergetic-Based Controllers for the Chemotherapy of Brain TumorMuhammad Zubair0Daniela Iacoviello1https://orcid.org/0000-0003-3506-1455Sheraz Ahmad Babar2https://orcid.org/0000-0003-4107-4420Department of Computer, Control and Management Engineering, Sapienza University of Rome, Rome, ItalyDepartment of Computer, Control and Management Engineering, Sapienza University of Rome, Rome, ItalyDepartment of Computer, Control and Management Engineering, Sapienza University of Rome, Rome, ItalyLumps formed by abnormal cell growth in the brain constitute brain tumors. Treatments differ depending on the specificity of the tumor and the condition of the patient; surgery, radiation therapy and targeted therapy are suggested for less severe tumors, while for severe tumors; chemotherapy is recommended. The last one, while being suggested and effective also in conjunction with surgery, has side effects that could be fatal. Therefore, it is mandatory to determine the appropriate dosage to obtain the desired effects without affecting healthy and immune cells. In this research work, advanced barrier function-based sliding mode and terminal synergetic-based controllers are designed to determine the amount of chemotherapy to eliminate tumor cells and maintain the right amount of healthy and immune cells. In particular, a barrier-based sliding mode controller is designed for dynamically controlling the chemotherapy drug for the tumor system, whereas the stability and convergence of the system are checked using the Lyapunov theory. The performance of the controller has been verified using MATLAB software based on different control parameters. The controller has remained successful in reducing the tumor cells and maintaining safe number of healthy and immune cells, showing favorable results in terms of steady-state error, over-under shoots, and rate of convergence.https://ieeexplore.ieee.org/document/10900338/Brain tumornonlinear controlbarrier function based sliding mode controlterminal synergetic controlchemotherapy
spellingShingle Muhammad Zubair
Daniela Iacoviello
Sheraz Ahmad Babar
Barrier Function and Terminal Synergetic-Based Controllers for the Chemotherapy of Brain Tumor
IEEE Access
Brain tumor
nonlinear control
barrier function based sliding mode control
terminal synergetic control
chemotherapy
title Barrier Function and Terminal Synergetic-Based Controllers for the Chemotherapy of Brain Tumor
title_full Barrier Function and Terminal Synergetic-Based Controllers for the Chemotherapy of Brain Tumor
title_fullStr Barrier Function and Terminal Synergetic-Based Controllers for the Chemotherapy of Brain Tumor
title_full_unstemmed Barrier Function and Terminal Synergetic-Based Controllers for the Chemotherapy of Brain Tumor
title_short Barrier Function and Terminal Synergetic-Based Controllers for the Chemotherapy of Brain Tumor
title_sort barrier function and terminal synergetic based controllers for the chemotherapy of brain tumor
topic Brain tumor
nonlinear control
barrier function based sliding mode control
terminal synergetic control
chemotherapy
url https://ieeexplore.ieee.org/document/10900338/
work_keys_str_mv AT muhammadzubair barrierfunctionandterminalsynergeticbasedcontrollersforthechemotherapyofbraintumor
AT danielaiacoviello barrierfunctionandterminalsynergeticbasedcontrollersforthechemotherapyofbraintumor
AT sherazahmadbabar barrierfunctionandterminalsynergeticbasedcontrollersforthechemotherapyofbraintumor